Legal News

Mylan Investigated for Antitrust Violations
Download PDF
1 Star2 Stars3 Stars4 Stars5 Stars (No Ratings Yet)


Summary: After increasing the price of EpiPens so that they are no longer affordable, drugmaker Mylan is being investigated for antitrust violations.

Mylan Pharmaceuticals is being investigated by New York state’s top legal office for the possibility that the drugmaker has broken antitrust laws over the pricing of its EpiPen. New York Attorney General Eric Schneiderman announced that a preliminary analysis had begun into Mylan by his office, including items such as the terms of sales in contracts with local schools.


Schneiderman said, “No child’s life should be put at risk because a parent, school or health care provider cannot afford a simple, life-saving device because of a drugmaker’s anti-competitive practices. Allergy sufferers have enough concerns to worry about – the availability of life-saving medical treatment should not be one of them.”

Read EpiPen CEO Tied to Democratic Senator.

EpiPen’s are the most popular method of epinephrine autoinjector on the market. The drug is used to treat those having a severe allergic reaction. Mylan increased the price of the EpiPen over 400 percent since 2009. This has raised concern by consumer advocates and critics.

Get JD Journal in Your Mail

Subscribe to our FREE daily news alerts and get the latest updates on the most happening events in the legal, business, and celebrity world. You also get your daily dose of humor and entertainment!!

A generic version was supposed to be made but the FDA has not approved one yet, leaving Mylan’s EpiPen as the only option for consumers that have to pay the price if they want to protect themselves and loved ones. Mylan has stated they will offer a generic version for $300 for the two-pack instead of the $600. They also state they will offer more discounts to make it affordable to users. The EpiPen brings in around $1 billion in profit a year for the pharmaceutical company.

See Big Pharma, Biotech Companies Ask for Patent Protections.

Mylan has given over 700,000 EpiPens for free to more than 65,000 schools across the country. They have also dropped the purchase requirement for schools looking to buy EpiPens at a discount.

Do you think Mylan has done anything wrong by dramatically increasing the price of the life-saving drug? Tell us in the comments below.

To learn more about Mylan, read Retaliation Lawsuit Brought Against Mylan Pharmaceuticals by Ex-Employee.



Interesting Legal Sites You May Like




Search Now

General Municipal Law Attorney with land use experience


Oakland office of our client seeks general municipal law attorney with experience advising public ag...

Apply Now

Mid-level Restructuring Attorney with bankruptcy experience


Washington, D.C. office of our client seeks mid-level restructuring attorney with 4-6 years of exper...

Apply Now

Senior Land Use Attorney with experience

USA-CA-San Francisco

San Francisco office of our client seeks senior land use attorney with 7+ years of experience. The c...

Apply Now

Attorney with 3-5 years of civil litigation experience


Merrillville office of our client seeks attorney with preferably 3-5 years of civil litigation exper...

Apply Now


Civil & Business Litigation / Transactional Attorney


Law firm with primary emphasis in Business & Civil Litigation and transactional work, seeks confiden...

Apply now



Boutique East Bay litigation defense firm is seeking a junior to mid-level attorney. Candidates for ...

Apply now

Family Law Paralegal


The right person for this job will grasp basic and complex divorce and family law issues, have stron...

Apply now

Products Liability & Mass Tort Litigation Associate


The candidate must have 1- 5 years of civil litigation experience, preferably with some background i...

Apply now

Most Popular


To Top